v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Cash flows from operating activities:      
Net loss $ (8,291) $ (839)  
Adjustments to reconcile net loss to net cash (used in) provided by operating activities      
Stock-based compensation expense 2,561 2,739  
Common stock contribution to 401(k) 88 102  
Depreciation and amortization 12 12  
Amortization of debt issuance costs, debt discount and final payment on debt 374 234  
Provision for bad debt 1,409    
Non-cash lease expense 74 976  
Change in fair value of equity securities 150 (746)  
Changes in assets and liabilities:      
Trade and other receivables, net 1,113 (1,151)  
Income tax receivable (1,526)    
Prepaid expenses and other assets (497) (368)  
Accounts payable and accrued liabilities (152) 193  
Unearned revenue recognized under units-of-revenue method (695) (442)  
Operating lease liabilities (79) (1,073)  
Other liabilities 309 427  
Net cash (used in) provided by operating activities (5,150) 64  
Cash flows from investing activities:      
Payments related to purchase of royalty rights   (6,300)  
Net cash used in investing activities   (6,300)  
Cash flows from financing activities:      
Proceeds from issuance of common stock, net of issuance costs 26 17  
Proceeds from exercise of options 25 257  
Proceeds from issuance of long-term debt   3,000  
Payment of stock issuance costs (211) (377)  
Principal payments - debt (1,875)    
Principal payments - finance lease (9) (7)  
Proceeds from disgorgement of stockholder's short-swing profits 13    
Taxes paid related to net share settlement of equity awards (16) (107)  
Net cash (used in) provided by financing activities (2,047) 2,783  
Net decrease in cash (7,197) (3,453)  
Cash at the beginning of the period 56,688 45,780 $ 45,780
Cash at the end of the period 49,491 42,327 $ 56,688
Supplemental Cash Flow Information:      
Cash paid for interest 379 217  
Non-cash investing and financing activities:      
Interest added to principal balance on long-term debt 317 376  
Accrued cost related to issuance of stock $ 19    
Issuance of common stock warrant under SVB loan   66  
Estimated fair value of contingent consideration under the royalty purchase agreements   $ 3,075  

Source